Picture of Orexo AB logo

ORX Orexo AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Orexo Extends Patent Protection In US

April 17 (Reuters) - Orexo AB  ORX.ST :
    * OREXO EXTENDS PATENT PROTECTION FOR ITS NASAL EPINEPHRINE
POWDER
PRODUCT OX640 IN THE US
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
ANOTHER US PATENT SPECIFICALLY RELATED TO OX640
    * NEWLY ISSUED PATENT, US PATENT NO. 11,957,647, PROVIDES
BOTH
EXPANDED SCOPE OF PROTECTION AS WELL AS LONGER PATENT TERM, NOW
EXTENDING UNTIL NOVEMBER 2042
    * EXPECTS TO CONTINUOUSLY STRENGTHEN PATENT PORTFOLIO FOR
OX640.

Source text for Eikon:  ID:nWkr5z8N94 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Orexo AB

See all news